These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38953298)

  • 1. Fabrication of pH-responsive temozolomide (TMZ)-clacked tannic acid-altered zeolite imidazole nanoframeworks (ZIF-8) enhance anticancer activity and apoptosis induction in glioma cancer cells.
    Ren C; Tu Q; He J
    J Biomater Sci Polym Ed; 2024 Sep; 35(13):1978-1998. PubMed ID: 38953298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-responsive resveratrol-loaded ZIF-8 nanoparticles modified with tannic acid for promoting colon cancer cell apoptosis.
    Sun X; Li F; Yuan L; Bing Z; Li X; Yang K
    J Biomed Mater Res B Appl Biomater; 2024 Jan; 112(1):e35320. PubMed ID: 37702969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acidic Environment-Responsive Metal Organic Framework-Mediated Dihydroartemisinin Delivery for Triggering Production of Reactive Oxygen Species in Drug-Resistant Lung Cancer.
    Yan X; Zhao X; Fan M; Zheng W; Zhu G; Li B; Wang L
    Int J Nanomedicine; 2024; 19():3847-3859. PubMed ID: 38708182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of transferrin-targeted temozolomide nano-micelles and their anti-glioma effect.
    Yu J; Xue Y
    PeerJ; 2024; 12():e17979. PubMed ID: 39285923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoplatelets modified with RVG for targeted delivery of miR-375 and temozolomide to enhance gliomas therapy.
    Yang T; Zhang N; Liu Y; Yang R; Wei Z; Liu F; Song D; Wang L; Wei J; Li Y; Shen D; Liang G
    J Nanobiotechnology; 2024 Oct; 22(1):623. PubMed ID: 39402578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
    Mao J; Meng X; Zhao C; Yang Y; Liu G
    Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment.
    Peng Y; Huang J; Xiao H; Wu T; Shuai X
    Int J Nanomedicine; 2018; 13():3467-3480. PubMed ID: 29942129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild thermotherapy and hyperbaric oxygen enhance sensitivity of TMZ/PSi nanoparticles via decreasing the stemness in glioma.
    Zeng X; Wang Q; Tan X; Jia L; Li Y; Hu M; Zhang Z; Bai X; Zhu Y; Yang X
    J Nanobiotechnology; 2019 Apr; 17(1):47. PubMed ID: 30935403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Anticancer Effects of Formononetin and Temozolomide on Glioma C6 Cells.
    Zhang X; Ni Q; Wang Y; Fan H; Li Y
    Biol Pharm Bull; 2018 Aug; 41(8):1194-1202. PubMed ID: 29848900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnosic acid potentiates the anticancer effect of temozolomide by inducing apoptosis and autophagy in glioma.
    Shao N; Mao J; Xue L; Wang R; Zhi F; Lan Q
    J Neurooncol; 2019 Jan; 141(2):277-288. PubMed ID: 30460630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano-Scaled Zeolitic Imidazole Framework-8 as an Efficient Carrier for the Intracellular Delivery of RNase A in Cancer Treatment.
    Jia J; Zhang S; Wen K; Li Q
    Int J Nanomedicine; 2019; 14():9971-9981. PubMed ID: 31908453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyoxometalate Modified by Zeolite Imidazole Framework for the pH-Responsive Electrodynamic/Chemodynamic Therapy.
    Song Y; Sun Y; Tang M; Yue Z; Ni J; Zhao J; Wang W; Sun T; Shi L; Wang L
    ACS Appl Mater Interfaces; 2022 Feb; 14(4):4914-4920. PubMed ID: 35050579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscone restores anoikis sensitivity in TMZ-resistant glioblastoma cells by suppressing TOP2A via the EGFR/Integrin β1/FAK signaling pathway.
    Zou Y; Xu L; Wang W; Zhu X; Lin J; Li H; Chen J; Xu W; Gao H; Wu X; Yin Z; Wang Q
    Phytomedicine; 2024 Jul; 129():155714. PubMed ID: 38723526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential delivery of dual drugs with nanostructured lipid carriers for improving synergistic tumor treatment effect.
    Xu M; Li G; Zhang H; Chen X; Li Y; Yao Q; Xie M
    Drug Deliv; 2020 Dec; 27(1):983-995. PubMed ID: 32611218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma.
    Xu JX; Yang Y; Zhang X; Luan XP
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1922-1931. PubMed ID: 32141561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
    Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
    Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor NGF, and Temozolomide: Impact on the Mitochondrial Metabolism, Clonogenic Potential, and Migration of Human U251 Glioma Cells.
    Chernov AN; Filatenkova TA; Glushakov RI; Buntovskaya AS; Alaverdian DA; Tsapieva AN; Kim AV; Fedorov EV; Skliar SS; Matsko MV; Galimova ES; Shamova OV
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Photothermal Tumor Immunotherapy by 1-MT Based on Zeolitic Imidazolate Framework-8 with pH-High Sensitivity.
    Su R; Yang Y; Wu H; Liu B; Tian X; Zhou C; Hu Y; Liu T
    Int J Nanomedicine; 2024; 19():8501-8517. PubMed ID: 39185344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theranostic nanoparticles ZIF-8@ICG for pH/NIR-responsive drug-release and NIR-guided chemo-phototherapy against non-small-cell lung cancer.
    Lu K; Pan X; Zheng J; Cheng D; Zheng L; Zhang X
    J Mater Sci Mater Med; 2024 Jun; 35(1):32. PubMed ID: 38896160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.